



Alcohol intake, ADH1B and ADH1C genotypes, and the
risk of colorectal cancer by sex and subsite in the
Netherlands Cohort Study
Citation for published version (APA):
Offermans, N. S. M., Ketcham, S. M., van den Brandt, P. A., Weijenberg, M. P., & Simons, C. C. J. M.
(2018). Alcohol intake, ADH1B and ADH1C genotypes, and the risk of colorectal cancer by sex and
subsite in the Netherlands Cohort Study. Carcinogenesis, 39(3), 375-388.
https://doi.org/10.1093/carcin/bgy011





Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 02 Nov. 2021
Received: October 12, 2017; Revised: December 19, 2017; Accepted: January 25, 2018
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Carcinogenesis, 2018, Vol. 39, No. 3, 375–388
doi:10.1093/carcin/bgy011




Alcohol intake, ADH1B and ADH1C genotypes, and 
the risk of colorectal cancer by sex and subsite in the 
Netherlands Cohort Study
Nadine S.M.Offermans1,†, Shannon M.Ketcham1,†, Piet A.van den Brandt1,2,  
Matty P.Weijenberg1 and Colinda C.J.M.Simons1,* 
1Department of Epidemiology, GROW – School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 
6200 MD Maastricht, the Netherlands and 2Department of Epidemiology, CAPHRI – School for Public Health and Primary 
Care, Maastricht University Medical Centre, Maastricht, The Netherlands 
* To whom correspondence should be addressed. Tel: +31 43 3882876; Fax: +31 43 3884128; Email: colinda.simons@maastrichtuniversity.nl
† These authors contributed equally to this work.
Abstract
The alcohol–colorectal cancer (CRC) association may differ by sex and ADH1B and ADH1C genotypes. ADH enzymes 
oxidize ethanol to acetaldehyde, both of which are human carcinogens. The Netherlands Cohort Study includes 120 852 
participants, aged 55–69 years at baseline (1986), and has 20.3 years follow-up (case-cohort: nsubcohort = 4774; ncases = 4597). The 
baseline questionnaire included questions on alcohol intake at baseline and 5 years before. Using toenail DNA, available 
for ~75% of the cohort, we successfully genotyped six ADH1B and six ADH1C SNPs (nsubcohort = 3897; ncases = 3558). Sex- and 
subsite-specific Cox hazard ratios and 95% confidence intervals for CRC were estimated comparing alcohol categories, 
genotypes within drinkers and alcohol categories within genotype strata. We used a dominant genetic model and adjusted 
for multiple testing. Alcohol intake increased CRC risk in both sexes, though in women only in the (proximal) colon when 
in excess of 30 g/day. In male drinkers, ADH1B rs4147536 increased (distal) colon cancer risk. In female drinkers, ADH1C 
rs283415 increased proximal colon cancer risk. ADH1B rs3811802 and ADH1C rs4147542 decreased CRC risk in heavy  
(>30 g/day) and stable drinkers (compared to 5 years before baseline), respectively. Rs3811802 and rs4147542 significantly 
modified the alcohol-colon cancer association in women (Pfor interaction = 0.004 and 0.02, respectively). A difference in 
associations between genotype strata was generally clearer in men than women. In conclusion, men showed increased CRC 
risks across subsites and alcohol intake levels, while only colon cancer risk was increased in women at heavy intake levels. 
ADH1B rs3811802 and ADH1C rs4147542 significantly modified the alcohol–colon cancer association in women. 
Introduction
Alcohol intake is a known risk factor for colorectal cancer (CRC), 
both the colon and rectum, and various other cancers including 
cancers of the oral cavity, pharynx, larynx, esophagus, liver and 
female breast (1,2). Cancer risk has been shown to increase as 
the volume of alcohol consumed increases (3). Sex differences 
may exist, with CRC risk being more strongly affected by alco-
hol intake in men than women (4) and a dose–response relation 
being less apparent in women than men (5). While this may be 
due to a restriction of range effect because women consume less 
alcohol than men, part of these differences may also simply be 
due to the scarcity of studies on the alcohol–CRC association in 
women (4).
The alcohol dehydrogenase (ADH) and aldehyde dehydro-
genase (ALDH) gene families encode for enzymes responsible 
for the breakdown of alcohol in the body. Ethanol is oxidized by 
ADH to acetaldehyde, which is in turn oxidized by ALDH to ace-
tate (6,7). The formation of acetaldehyde starts in the mouth and 
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acetaldehyde occurring in the liver and the gut (1). Both ethanol 
and acetaldehyde have been classified as human carcinogens 
by the International Agency for Research on Cancer (IARC) (6). 
Genetic variants [i.e. single nucleotide polymorphisms (SNPs)] 
in ADH and ALDH genes have been shown to affect enzyme 
activities resulting in a slower or faster conversion of ethanol to 
acetaldehyde and acetaldehyde to acetate (7,8). The ALDH2 rs671 
gene variant strongly determines the slow rate at which most of 
the ethanol-derived acetaldehyde is oxidized, resulting in acet-
aldehyde accumulation  when carrying the minor allele, espe-
cially when also  carrying ADH genotypes associated with fast 
ethanol to acetaldehyde conversion, e.g. for  ADH1B rs1229984. 
This results in the facial flushing syndrome known in Asian 
populations (7). In Caucasians, however, the rs671 allele caus-
ing slow oxidation of acetaldehyde is largely absent (9). ADH1B 
and ADH1C, on the other hand, have functional polymorphisms 
in Caucasian populations (7), but most previous epidemiological 
studies on SNPs in these genes and the risk of CRC had low sam-
ple sizes (10,11). In the absence of ALDH alleles causing slow oxi-
dation of acetaldehyde, increased cancer risks may be explained 
by fast conversion of ethanol to acetaldehyde in the liver, result-
ing in higher systemic levels of acetaldehyde, potentially reach-
ing the colorectum. Alternatively, slow conversion of ethanol to 
acetaldehyde in the liver results in ethanol circulating the blood 
for longer periods of time. Circulating ethanol may expose the 
colorectum to locally formed levels of acetaldehyde, depending 
on ADH activity in the colonic mucosa and conversion by intes-
tinal bacteria (12–15). Therefore, in the absence of data on how 
much ethanol or acetaldehyde accumulates in the colorectum, 
an association between alcohol intake and CRC risk in both slow 
and fast ethanol metabolizers is conceivable.
The objective of this study was twofold in that we first aimed 
to investigate the alcohol–CRC association by sex and subsite, 
specifically addressing the limited evidence in women, and sec-
ondly we aimed to investigate whether this association was 
modified by genetic variants in ADH1B and ADH1C. ADH1B and 
ADH1C variants were also studied in relation to CRC risk by sex 
and subsite in drinkers, where an effect may be expected. The 
study setting was a prospective cohort including 120 852 partici-
pants, who were followed up for 20.3 years (16). A former study 
in this cohort after 13.3 years follow-up found no evidence of an 
influence of alcohol on CRC risk, overall and by subsite, though 
the number of cases among the heavy drinkers was rather 
limited (i.e. ≥30  g of alcohol per day), hampering sex-specific 
analyses (17). Another study in this cohort, investigating the 
alcohol–CRC association by ADH1C rs698 genotype strata after 
7.3 years follow-up found no apparent evidence of effect modi-
fication, but the power was limited there as well (18). Therefore, 
we reinvestigated the alcohol–CRC association by sex and sub-
site and possible effect modification by rs698 and other ADH1B 
and ADH1C tagSNPs after 20.3  years of follow-up. Recently, 
Dutch recommendations with respect to alcohol intake for 
cancer prevention have been modified: from a maximum of two 
drinks daily for men and one drink daily for women to no al-
cohol intake for both sexes (2,19), and if consuming alcohol, no 
more than one drink daily (19). This revised recommendation 
may be particularly important for specific subgroups with an 
unfavorable genetic background.
Materials and methods
Design and study population
The Netherlands Cohort Study (NLCS) is a prospective cohort study which 
was initiated in 1986 and consists of 120 852 men and women who were 
aged 55–69 years old at baseline (16). Study participants completed a base-
line self-administered questionnaire on dietary habits, lifestyle factors 
and other risk factors for cancer. For efficiency reasons, the NLCS uses 
a case-cohort approach in which cases are enumerated from the entire 
cohort and the person-time at risk is estimated from a subcohort (20). 
This subcohort, consisting of 5000 participants, was randomly selected 
immediately after baseline, independent of any exposure. After exclusion 
of participants who reported a history of cancer (other than skin cancer) 
at baseline, 4774 subcohort members were left. Follow-up of vital status 
and migration for these participants was done through the Central Bureau 
of Genealogy and the municipal population registries (>99.9% complete-
ness). Follow-up for incident cancer cases was performed by record link-
age to the Dutch Cancer Registry and PALGA (the Netherlands pathology 
database) (21,22) (>96% completeness) (23). After 20.3 years follow-up, 4597 
CRC cases (ICD-O-3 codes C18-C20) were identified from the original co-
hort. The NLCS was approved by the institutional review boards of the 
Netherlands Organisation for Applied Scientific Research TNO (Zeist) and 
Maastricht University (Maastricht).
Exposure assessment
The baseline questionnaire included a 150-item semi-quantitative food 
frequency questionnaire (FFQ) containing questions on diet and alcohol 
intake. In addition to the questionnaire, participants in the NLCS were 
asked to return toenail clippings. Roughly 90 000 (~75%) of NLCS partici-
pants provided toenail clippings which were used as a source of DNA for 
genotyping (24,25). Using 20.3 years follow-up in the NLCS, DNA samples 
were available for 3558 CRC cases and 3897 subcohort members.
Alcohol intake and covariates
 Alcohol intake during the year preceding the start of the study was meas-
ured by questions on six different types of alcohol: beer; red wine; white 
wine; sherry and other fortified wines; liquor types containing on average 
16% alcohol; (Dutch) gin, brandy and whiskey. Participants were asked 
about the number of glasses they consumed during each drinking session 
and their usual frequency of alcohol drinking. Additionally, for the catego-
ries ‘beer’ and ‘other alcoholic beverages’, participants were asked to re-
call if they drank more, less, or the same amount of alcohol 5 years before 
baseline. The total amount of daily alcohol intake (g/day) was calculated 
using the information about how often the participants drank alcohol, the 
number of glasses they consumed during each drinking session and the 
types of alcohol they drank (i.e. their alcoholic content). We defined two 
alcohol categories: light-moderate alcohol intake as drinking >0 to <30 g of 
alcohol per day (>0 to <3 glasses of alcohol per day) and heavy alcohol in-
take as drinking 30 or more grams of alcohol per day (≥3 glasses of alcohol 
per day). Information on other covariates that were considered potential 
confounders on the basis of previous research was also available from the 
baseline questionnaire. The FFQ was validated against a 9-day diet record 
(26) and was tested for reproducibility (27). The adjusted Spearman correl-
ation coefficient between mean daily alcohol intake assessed by the FFQ 
and that estimated from the 9-day diet record was 0.89 for all participants 
and 0.85 for users of alcoholic beverages. The absolute amount of alcohol 
reported in the FFQ by users of alcoholic beverages was, on average, 86% 
of that reported in the 9-day diet record (26).
Selection and genotyping of tagging SNPs
Tagging SNPs (tagSNPs) within ADH1B and ADH1C (including 5 kb up- and 
downstream) were selected as to potentially cover all of the genetic vari-
ation in these genes with a minor allele frequency of 5% or higher. In total, 
Abbreviations 
ADH  alcohol dehydrogenase
ALDH  aldehyde dehydrogenase
CI  confidence interval
CRC  colorectal cancer
FFQ  food frequency questionnaire
FDR  false discovery rate
FFQ  food frequency questionnaire
NLCS  Netherlands Cohort Study
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13 tagSNPs were identified using the HapMap CEU (Utah Residents with 
Northern and Western European Ancestry) population, an r2 threshold 
of 0.8 and aggressive tagging. Seven of these (i.e. rs1159918, rs2075633, 
rs1693439, rs9307239, rs4147536, rs3811802, rs17033) represented 84% of 
the genetic variation in ADH1B and six (i.e. rs698, rs1662033, rs3114046, 
rs4147542, rs283415, rs4699741) represented 96% of the genetic variation in 
ADH1C (28). SNPs were genotyped using 50 ng of toenail DNA per partici-
pant, which was carried out using the iPLEXTM assay for the MassARRAY® 
system (Agena Bioscience GmbH, Hamburg, Germany). Samples had a 
mean call rate of 97.1% (as based on the 13 SNPs in ADH1B and ADH1C 
studied here and 10 other SNPs that were included in the assay). SNP call 
rates were 94% or higher, except for rs4147542, which had a SNP call rate 
of 87%. Two SNPs, ADH1C rs4699741 and ADH1C rs9307239, violated Hardy–
Weinberg equilibrium. When using a significance threshold of 0.05, one in 
twenty SNPs may be expected to show a violation on the basis of chance 
alone. Although two SNPs exceed this expectation by chance and we can-
not check conditions needed for Hardy–Weinberg, e.g. random mating, 
all SNPs were genotyped using a single assay, which makes it unlikely 
that these violations represent genotyping errors. Therefore, we conserva-
tively refrained from excluding these SNPs from the analysis. Genotyping 
for ADH1B rs17033 was unsuccessful (i.e. only the T allele was ampli-
fied) and therefore not included in our analyses as originally intended. 
Consequently, we used six ADH1B tagSNPs covering 76% of the genetic 
variation in ADH1B and six ADH1C tagSNPs covering 96% of the genetic 
variation in ADH1C.
Statistical analysis
Statistical analyses were carried out using Cox regression to calculate haz-
ard ratios (HR) and corresponding 95% confidence intervals (95% CI) for 
CRC by sex and subsite. Standard errors were estimated using the Huber–
White sandwich estimator to account for additional variance introduced 
by sampling the subcohort from the entire cohort. ADH1B and ADH1C 
genotypes were defined according to a dominant model for reasons of 
power. Categories of total alcohol intake (0.1–29 and ≥30 g/day) were com-
pared relative to abstaining (0  g/day). Trends were evaluated by includ-
ing categorical variables as continuous variables in the Cox regression 
model. The proportional hazards assumption was tested using the scaled 
Schoenfeld residuals and by visually inspecting the −log–log transformed 
hazard curves. Multiplicative interactions were tested using the Wald test. 
All tests (two-tailed) were performed using Stata (version 14) and differ-
ences were regarded as statistically significant at P < 0.05.
Marginal effects of alcohol intake on CRC
Multivariable-adjusted models were used to study the alcohol–CRC asso-
ciations. The covariates included were either a priori-selected risk fac-
tors based on the literature or variables that changed the HRs by at least 
10% (using a backwards stepwise procedure). This resulted in the follow-
ing confounder set: age (years), BMI (kg/m2), smoking (never/ex/current), 
family history of CRC (yes/no), meat intake (g/day), processed meat intake 
(g/day), folate intake (µg/day) and physical activity based on baseline non-
occupational physical activity (min/day) (29). Participants with incomplete 
or inconsistent questionnaires and missing information on alcohol intake 
and/or the predefined confounding factors were excluded from the ana-
lysis, leaving 4125 subcohort members and 3996 CRC cases (see Figure 1).
Associations between ADH1B and ADH1C tagSNPs and CRC 
risk in drinkers
We studied individual SNPs in relation to CRC risk in drinkers. Although 
small amounts of ethanol are produced endogenously, especially in the 
gastrointestinal tract (1), an effect of SNPs in alcohol-metabolizing genes 
may be expected in drinkers foremost as this is the group where the sub-
strate (alcohol) is available. We conservatively refrained from adjusting for 
Figure 1. Flow diagram of available subcohort members and colorectal cancer cases, Netherlands Cohort Study, 1986–2006. FU, follow-up. AAnalysis 1 is on the marginal 
effects of alcohol intake on CRC. BAnalysis 2 is on the associations between ADH1B and ADH1C tagSNPs and CRC risk in drinkers. CAnalysis 3 is on effect modification 
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factors other than age because it is unlikely that ADH1B and ADH1C geno-
types are influenced by CRC risk factors in lifestyle and diet. Participants 
were excluded from the analysis if no toenail DNA sample was available, 
the sample call rate was less than 90%, the baseline questionnaire was 
incomplete or inconsistent, or information on alcohol intake was miss-
ing (see Figure 1).This resulted in 2526 subcohort members and 2491 CRC 
cases.
Effect modification of the alcohol–CRC association by ADH1B 
and ADH1C tagSNPs
Multivariable-adjusted models were used to study effect modification 
of the alcohol–CRC association by ADH1B and ADH1C tagSNPs, using the 
confounder set as described for the alcohol–CRC analyses. After excluding 
participants without available DNA samples, with a sample call rate of 
less than 90%, with incomplete or inconsistent questionnaires and with-
out complete information on alcohol intake and/or the predefined con-
founding factors, 3150 subcohort members and 2985 CRC cases were left 
for analysis (see Figure 1).
Multiple testing
Because multiple tests were conducted within each gene, we applied the 
false discovery rate (FDR) control method of Benjamini and Hochberg 
(30,31) to address the issue of multiple testing. To accomplish this, P-values 
calculated from our analyses were ranked in ascending order. Gene- and 
endpoint-specific Benjamini adjusted P-values were calculated by divid-
ing the P-value rank order by the total number of P-values and then mul-
tiplying this number by the FDR [i.e. the recommended 20% (32)]. If the 
original P-value was less than 0.05 and fell below the adjusted P-value, it 
was considered significant.
Sensitivity analyses
Drinking patterns over a longer duration of time may influence CRC risk 
differently or more profoundly than when evaluated on a single time point. 
For instance, stronger alcohol–CRC associations may be expected in those 
with a relatively constant long-term exposure to alcohol. As the NLCS has 
data available on alcohol intake 5  years before baseline, we conducted 
sensitivity analyses using these data. This included restricting the analy-
ses on alcohol–CRC associations and effect modification to participants 
who reported to have had the same alcohol intake 5 years before baseline, 
which included abstainers on both occasions (i.e. the stable subgroup). For 
the SNP-CRC analyses in drinkers, this included restriction to those drink-
ing equal amounts of alcohol 5 years before baseline (i.e. the stable drink-
ers). We also evaluated whether there may be a threshold level of alcohol 
intake at which individual SNPs start to influence CRC risk by stratifying 
SNP–CRC associations on alcohol intake level (light-moderate and heavy). 
Furthermore, because changes in reported alcohol intake may indicate 
underlying reasons such as health issues or exposure misclassification, 
possibly due to underreporting, we repeated the alcohol–CRC analyses 
restricting once to baseline drinkers who reported drinking less alcohol 
5 years before baseline and once to baseline drinkers who reported drink-
ing more alcohol 5 years before baseline. Finally, we checked for the risk of 
protopathic bias by excluding the first 2 years of follow-up (with no essen-
tial changes in results), as this may be especially likely when investigating 
alcohol intake in relation to cancer risk.
Results
Baseline characteristics
Table 1 shows the baseline characteristics of subcohort mem-
bers and CRC cases. As regards alcohol intake, men were less 
often abstainers as compared to women and men were more 
likely to consume higher levels of alcohol than women, espe-
cially male CRC cases.
Marginal effects of alcohol intake on CRC
Alcohol intake was positively associated with CRC risk in both 
men and women (Table 2). In women, however, only colon cancer 
risks, in particular proximal colon cancer risk, were increased, but 
not until alcohol intake exceeded 30 g/day [HRheavy drinkers versus abstainers 
(95% CI)  =  1.52 (1.03–2.24), 1.70 (1.09–2.66) and 1.25 (0.71–2.20) 
for colon, proximal colon and distal colon cancer, respectively]. 
In men, colon and rectal cancer risks were both increased and 
there were also non-significantly increased risks in men who 
consumed a light-moderate amount of alcohol versus abstainers 
Table 1. Distribution of potential confounders and alcohol intake among subcohort members and CRC cases in the NLCS, 1986–2006
Male subcohort Male CRC cases Female subcohort Female CRC cases
N (%) Mean (SD) N (%) Mean (SD) N (%) Mean (SD) N (%) Mean (SD)
Age (years) 61.4 (4.2) 61.8 (4.2) 61.5 (4.3) 62.1 (4.1)
Alcohol intake (g/day)
 0 329 (14.5) 303 (12.1) 731 (32.7) 599 (31.7)
 0.1–4 479 (21.1) 549 (22.0) 806 (36.0) 692 (36.6)
 5–14 621 (27.3) 630 (25.2) 417 (18.6) 348 (18.4)
 15–29 505 (22.2) 593 (23.7) 207 (9.3) 168 (8.9)
 ≥30 339 (14.9) 426 (17.0) 77 (3.4)  84 (4.4)
BMI (kg/m2) 25.0 (2.6) 25.3 (2.7) 25.1 (3.6) 25.1 (3.5)
Smoking
 Never 300 (12.9) 313 (12.3) 1431 (58.9) 1190 (58.7)
 Ex 1175 (50.4) 1463 (57.3) 491 (20.2) 438 (21.6)
 Current 856 (36.7) 777 (30.4) 509 (20.9) 398 (19.6)
Family history of CRC
 Yes 118 (5.1) 219 (8.6) 134 (5.5) 189 (9.3)
 No 2213 (94.9) 2336 (91.4) 2298 (94.5) 1840 (90.7)
Meat intake (g/day) 104.9 (44.1)  105.3 (43.2) 92.2 (41.1) 90.6 (40.9)
Processed meat intake (g/day) 15.6 (16.9)  16.3 (16.8) 10.3 (11.9) 10.2 (11.3)
Folate intake (µg/day) 222 (77)  219 (72) 195 (71) 194 (71)
Non-occupational physical activity (min/day)
 ≤30 447 (19.5) 431 (17.1) 639 (26.8) 596 (29.9)
 >30–60 710 (30.9) 776 (30.8) 737 (30.9) 598 (30.0)
 >60–90 419 (18.3) 497 (19.7) 518 (21.7) 451 (22.6)
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[HRlight-moderate drinkers versus abstainers (95% CI) = 1.21 (0.97–1.50), 1.23 (0.93–
1.63), 1.23 (0.93–1.63) and 1.10 (0.82–1.48) for colon, proximal colon, 
distal colon and rectal cancer, respectively]. In addition, there 
was a statistically significant positive linear trend across alco-
hol intake categories in men, except for proximal colon cancer. 
When restricting to the stable subgroup, more pronounced asso-
ciations were observed between alcohol intake and CRC risk in 
men, while statistically significant associations were no longer 
observed in women, but this may be explained by limited power. 
Remarkably, male heavy drinkers as compared to light-moderate 
drinkers reporting more alcohol intake 5  years before baseline 
had decreased CRC risks across subsites. Possibly, men who still 
reported to be heavy drinkers at baseline endure alcohol better 
than light-moderate drinkers who reported more alcohol intake 
5 years before baseline. In the subanalysis in male drinkers report-
ing less alcohol intake 5 years before baseline, HRs were around 
the null for heavy drinkers as compared to light-moderate drink-
ers. In female drinkers who reported more and those who reported 
less alcohol intake 5  years before baseline, (non-significantly) 
increased risks of CRC were observed for heavy drinkers as com-
pared to light-moderate drinkers, though the power was limited.
Associations between ADH1B and ADH1C tagSNPs 
and CRC risk in drinkers
Tables 3 and 4 show associations between ADH1B and ADH1C 
tagSNPs and CRC risk overall and by subsite in male and female 
drinkers, respectively, as analyzed according to a dominant 
model. Only FDR significant results will be mentioned below. 
ADH1B rs4147536 was associated with the risk of colon cancer 
and distal colon cancer in male drinkers [HRCA/AA versus CC (95% 
CI)  =  1.25 (1.05–1.48) and 1.32 (1.07–1.62), respectively]. ADH1C 
rs283415 was associated with the risk of proximal colon can-
cer in female drinkers [HRTC/CC versus TT (95% CI) = 1.39 (1.08–1.80)]. 
Restricting these analyses to the stable drinkers revealed a stat-
istically significant association between ADH1C rs4147542 and 
CRC risk in women [HRTC/CC versus TT (95% CI)  =  0.73 (0.57–0.93)]. 
Stratifying these analyses by alcohol intake amount (i.e. light-
moderate and heavy) to evaluate a potential threshold level of 
alcohol intake at which individual SNPs start to influence CRC 
risk revealed a statistically significant association between 
ADH1B rs3811802 and CRC risk in women who were heavy 
drinkers at baseline (>30  g/day) [HRAG/GG versus AA (95% CI)  =  0.19 
(0.07–0.50)], while no significant associations were observed in 
light-moderate drinkers. The results of both sensitivity analy-
ses are presented in Supplementary Tables 1 and 2, available at 
Carcinogenesis Online.
Effect modification of the alcohol–CRC association by 
ADH1B and ADH1C tagSNPs
Table 5 shows the associations between alcohol intake and CRC 
risk in men and women, stratified by genotype, as analyzed 
according to a dominant model. The alcohol–CRC associations 
observed in genotype strata generally aligned with overall alco-
hol–CRC associations. HRs around the null were observed in 
one stratum and a pattern of increasing risks across alcohol 
categories was observed in the other stratum in men, while a 
difference in associations between genotype strata was less 
clear in women. Statistically significantly increased HRs for 
CRC were only present when comparing heavy drinkers with 
abstainers. Most interactions were not significant after FDR cor-
rection except for the interactions between alcohol intake and 
ADH1B rs3811802 and ADH1C rs4147542 in women. Risk was 
strongly increased in heavy (but not light-moderate) drinkers 
versus abstainers in female rs3811802 AA carriers, although the 
CI around this estimate is large [HR (95% CI) 5.72 (2.24–14.63)], 
while the risk across alcohol categories in female rs3811802 AG/
GG carriers remained almost unchanged. In female rs4147542 
TT carriers, there was a significant positive trend in CRC risk 
with increasing alcohol intake [HRlight-moderate drinkers versus abstainers (95% 
CI) 1.25 (0.98–1.59) and HRheavy drinkers versus abstainers (95% CI) 1.78 (1.01–
3.14)], while a decreased risk was observed for light-moderate 
drinkers and an increased risk for heavy drinkers relative to 
abstainers in female rs4147542 TC/CC carriers [HR (95% CI) 0.78 
(0.60–1.02) and HR (95% CI) 1.74 (0.92–3.31), respectively]. After 
restricting the analysis to the stable subgroup (Supplementary 
Table 3, available at Carcinogenesis Online), only the interaction 
between alcohol intake and ADH1C rs4147542 in relation to CRC 
risk in women remained significant after FDR correction. In add-
ition, in men, results were more pronounced, showing stronger 
increased HRs for CRC in heavy drinkers as compared with 
abstainers and more significant positive trends.
Supplementary Tables 4–7, available at Carcinogenesis Online, 
show the associations between alcohol intake and the risk of 
CRC by subsite, i.e. the colon, proximal colon, distal colon and 
rectum, in men and women, stratified by genotype. After FDR 
correction, the only statistically significant interactions observed 
were those between alcohol intake and ADH1B rs3811802 and 
ADH1C rs4147542 in relation to (proximal) colon cancer in 
women, consistent with the interactions observed for CRC 
in women. In men, a difference in associations was observed 
between genotype strata, when considering alcohol intake in 
relation to the risk of colon and proximal colon cancer, and, in 
particular, rectal cancer, but less so or not in relation to distal 
colon cancer. In women, the power was limited in analyses for 
distal colon and rectal cancer, hampering a proper comparison.
Discussion
This study addressed the lack of evidence regarding alcohol 
intake and CRC risk in women and found alcohol to be a CRC 
risk factor in men and women. Associations with CRC differed 
by sex. Alcohol intake increased CRC risk (non-)significantly 
at light-moderate and heavy intake levels across subsites in 
men. Only when alcohol intake exceeded 30 g/day, we observed 
increased colon cancer risks, particularly for the proximal colon, 
in women. We studied associations in ADH1B and ADH1C gen-
etic subgroups, because these may be particularly susceptible to 
the deleterious effects of alcohol on CRC risk. ADH1B rs3811802 
and ADH1C rs4147542 modified the association between al-
cohol intake and the risk of colorectal, colon and proximal colon 
cancer in women after FDR correction. The alcohol–CRC associa-
tions observed in genotype strata generally aligned with overall 
alcohol–CRC associations. A difference in associations between 
genotype strata was generally clearer in men than women but 
significant effect modification was only present in women. 
Restricting to participants with equal alcohol intake amounts 
5  years before baseline resulted in (more) significant positive 
linear trends across alcohol intake categories within genotype 
strata in men but not women. Furthermore, ADH1B rs4147536 
and ADH1C rs283415—which was in strong linkage disequilib-
rium (LD) with the commonly investigated ADH1C rs698 (r2 = 0.9) 
in our data—were associated with an increased cancer risk at 
colon subsites in male and female drinkers, respectively, after 
FDR correction. ADH1B rs3811802 and ADH1C rs4147542 were 
associated with a decreased CRC risk in female heavy and 
stable drinkers, respectively, after FDR correction. These results 
substantiate the interplay between alcohol intake, ADH1B and 
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A potential sex difference in intake levels at which alcohol 
intake increases CRC risk may in part be explained by differ-
ences in drinking pattern. Men perhaps are more likely to be 
more regular consumers than women. Regular alcohol expo-
sure may be especially deleterious and may also increase CRC 
risk at light-moderate levels (33). In addition, sex differences in 
first-pass metabolism of alcohol (i.e. presystemic elimination 
of ethanol in, predominantly, the stomach and liver (34)) and 
ADH activity could lead to sex differences in the CRC risk asso-
ciated with alcohol intake (35). Women have prolonged, higher 
blood ethanol concentrations than men upon similar intake 
levels due to differences in elimination of alcohol (i.e. the vol-
ume distribution is higher in men than women) (35). However, 
based on this, one would expect women to be affected by alco-
hol at lower intake levels than men, whereas we found a non-
significant association with CRC risk at light-moderate alcohol 
intake levels in men but not women. A  more plausible expla-
nation, therefore, may be that there are interactions between 
alcohol intake and sex-specific factors. For example, women 
might be protected from the adverse effects of alcohol at light-
moderate intake levels through a positive relationship between 
alcohol intake and estradiol levels (35). Increased estradiol lev-
els were found to be protective against CRC in women (36,37). 
Alternatively, as suggested by Klatsky et al. (38), an increased risk 
of cancer among light-moderate drinkers may be due in part to 
the underreporting of heavy alcohol intake. This could explain 
the associations observed with light-moderate alcohol intake 
in men as the percentage of heavy drinkers is higher in men 
than women (even though underreporting may be expected 
more in women than men due to social desirability standards). 
Finally, the fact that a sex difference was very pronounced in 
relation to rectal cancer could indicate that there may have been 
some residual confounding by smoking, even after adjusting for 
smoking. Smoking has been more strongly associated with rec-
tal cancer than colon cancer risk (39), and smoking correlated 
more strongly with alcohol intake in men than women [88% of 
male drinkers as compared to 48% of female drinkers in the sub-
cohort were ever smokers].
We found that the association between alcohol intake and 
(proximal) colon cancer risk in women was significantly modi-
fied by ADH1B rs3811802 and ADH1C rs4147542 after FDR cor-
rection. The SNPs selected in this study were not selected on 
the basis of that these were strong causal variants per se, but on 
the basis of that these common SNPs (minor allele frequency 
>5%) tag the genetic variation in ADH1B and ADH1C. Considering 
that tagSNPs generally confer only minor risks, which may be 
explained by imperfect correlations with true causal variants 
and gene–gene interactions, it is difficult to show significance 
in gene-environment interaction studies, even with large sam-
ple sizes (40). Therefore, it may be considered remarkable that 
two SNPs modified the association between alcohol intake and 
(proximal) colon cancer risk  in women after FDR correction. 
Especially ADH1C rs4147542 is noteworthy in this regard since 
it can be linked to functional evidence: it is an expression quan-
titative trait locus (eQTL) for ADH1C in several tissues including 
the transverse colon (41), and has been reported to be a meth-
ylation quantitative trait locus (mQTL) (42). DNA methylation 
might, in part, underlie our finding of a gene–environment inter-
action between rs4147542 and alcohol intake which was spe-
cific to proximal colon cancer risk and to women, in which the 
CpG island methylator phenotype (CIMP) is present more often 
(43,44). Curtin et al. (45) showed that ADH1C rs698 was associ-
ated with CRCs positive for CIMP in those with low folate intake. 
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one-carbon metabolism (46), and folate is an important methyl 
donor. On the other hand, other studies have not specifically 
linked alcohol intake to CIMP in CRC (47–49).
Of the four other tagSNPs (ADH1B rs4147536 and rs3811802 
and ADH1C rs283415 and rs4147542) that were associated with 
CRC risk in drinkers—also suggesting interplay between alcohol 
intake, ADH1B and ADH1C, and CRC risk—rs283415 is in strong 
LD with the commonly investigated rs698, for which functional 
evidence is available. ADH1C rs698 C-allele carriers who also 
carry the rs1693482 A-allele, encoding Ile350Val and Arg272Gln 
substitutions, respectively (50), have a ~2.5 times slower alcohol 
metabolizing rate (51,52) and were found to be at an increased 
risk of alcohol dependence in Asian populations (7). However, 
the evidence linking rs698 to cancer was judged inconclusive 
by IARC due to the small number of studies (1). A meta-analysis 
of 35 case–control studies comparing rs698 slow with faster al-
cohol metabolizers found an association with the risk of cancer 
overall in African and Asian but not European populations 
(53). This suggests ethnicity is an important factor to take into 
account. For example, in Caucasian populations there is uncer-
tainty around whether slow or fast alcohol metabolizers are at 
an increased CRC risk. Although Caucasians carry ADH alleles 
affecting ethanol oxidation, they lack ADH alleles causing very 
fast oxidation of ethanol and also lack ALDH alleles causing slow 
oxidation of acetaldehyde. As such, conflicting results may have 
emerged from Caucasian studies on rs698 (54,55) in the absence 
of data on how much ethanol or acetaldehyde accumulates in 
the colorectum, as explained in the introduction.
Strengths of the present study include the population-based 
prospective design and long follow-up, yielding large case num-
bers and making selection and information bias unlikely. In 
addition, the NLCS contains information on alcohol intake at 
baseline as well as 5  years before baseline, allowing us to in-
vestigate whether drinking patterns or fluctuations in alcohol 
intake affected the studied associations. Information on po-
tential confounders was based on a single baseline measure-
ment, and although changes over time cannot be excluded, the 
NLCS population has been found stable in its dietary habits (16). 
Importantly, the elaborate available baseline information ena-
bled us to adjust for a large set of relevant confounders. This 
is essential considering that individuals who consume higher 
levels of alcohol may in general have an unhealthier lifestyle 
than those who have lower intake levels. Furthermore, the high 
genotyping quality may also be considered as a strength.
In conclusion, as opposed to men who showed increased CRC 
risks across subsites and alcohol intake levels, alcohol intake 
only increased colon cancer risk in women and only at heavy 
intake levels. ADH1B rs3811802 and ADH1C rs4147542 modified 
the alcohol–CRC association in women. These data indicate 
that alcohol may be a particularly important CRC risk factor in 
specific genetic subgroups. Previous literature indicates a func-
tional role of rs4147542, supporting our finding of an effect of 
this variant on alcohol-associated colorectal carcinogenesis and 
strengthening our confidence in covering relevant genetic vari-
ation in ADH1B and ADH1C.
Supplementary material
Supplementary data are available at Carcinogenesis online.
Funding
This work was supported by the European Foundation for Alcohol 




































































































































































































































































































































































































































































































































































































































































































































































aastricht user on 13 January 2021
N.S.M.Offermans et al. | 387
and Biomolecular Research Infrastructure Netherlands (to M.P.W.) 
and the Health Foundation Limburg (to M.P.W.).
Acknowledgements
We are indebted to the participants of this study and wish to 
thank the Netherlands Cancer Registry and the Netherlands 
nationwide registry of pathology (PALGA). We also thank 
Drs. A.  Volovics, and A.  Kester for statistical advice; S.  van de 
Crommert, H. Brants, J. Nelissen, C. de Zwart, M. Moll, W. van 
Dijk and A.  Pisters for data management; H.  Hoofs, H.  van 
Montfort, T. van Moergastel, L. van den Bosch, R. Schmeitz and 
J.  Berben for programming assistance; L.  Jonkers, J.  Goessens, 
K. Lemmens and S. Lumeij for the laboratory work involved; and 
the Biobank Maastricht UMC+ for sample storage.
Conflict of Interest Statement: None declared.
References
 1. International Agency for Research on Cancer. (2012) IARC Monographs 
on the Evaluation of Carcinogenic Risks to Humans: Personal Habits 
and Indoor Combustions: Consumption of Alcoholic Beverages. 
International Agency for Research on Cancer, Lyon, France. 
 2. WCRF|Continuous Update Project. Alcohol and Cancer. http://www.
wcrf.org/int/cancer-facts-figures/link-between-lifestyle-cancer-risk/
alcohol-cancer (18 December 2017, date last accessed).
 3. Rehm, J. et  al. (2003) The global distribution of average volume of 
alcohol consumption and patterns of drinking. Eur. Addict. Res., 9, 
147–156.
 4. WCRF|Continuous Update Project. Colorectal cancer. http://www.
wcrf.org/sites/default/files/Colorectal-Cancer-2011-Report.pdf (18 
December 2017, date last accessed).
 5. Fedirko, V. et al. (2011) Alcohol drinking and colorectal cancer risk: an 
overall and dose-response meta-analysis of published studies. Ann. 
Oncol., 22, 1958–1972.
 6. Baan, R. et  al.; WHO International Agency for Research on Cancer 
Monograph Working Group. (2007) Carcinogenicity of alcoholic bever-
ages. Lancet. Oncol., 8, 292–293.
 7. Hurley, T.D. et al. (2012) Genes encoding enzymes involved in ethanol 
metabolism. Alcohol Res., 34, 339–344.
 8. Seitz, H.K. et al. (2007) Molecular mechanisms of alcohol-mediated car-
cinogenesis. Nat. Rev. Cancer, 7, 599–612.
 9. Zerbino, D.R. et al. (2018) Ensembl 2018. Nucleic Acids Res., 46, D754–
D761. doi:10.1093/nar/gkx1098.
 10. Ferrari, P. et al. (2012) Alcohol dehydrogenase and aldehyde dehydro-
genase gene polymorphisms, alcohol intake and the risk of colorec-
tal cancer in the European Prospective Investigation into Cancer and 
Nutrition study. Eur. J. Clin. Nutr., 66, 1303–1308.
 11. Martínez, C. et al. (2010) Variability in ethanol biodisposition in whites 
is modulated by polymorphisms in the ADH1B and ADH1C genes. 
Hepatology, 51, 491–500.
 12. Jokelainen, K. et al. (1994) In vitro acetaldehyde formation by human 
colonic bacteria. Gut, 35, 1271–1274.
 13. Jokelainen, K. et  al. (1996) In vitro alcohol dehydrogenase-mediated 
acetaldehyde production by aerobic bacteria representing the normal 
colonic flora in man. Alcohol. Clin. Exp. Res., 20, 967–972.
 14. Pestalozzi, D.M. et  al. (1983) Immunohistochemical localization 
of alcohol dehydrogenase in the human gastrointestinal tract. 
Gastroenterology, 85, 1011–1016.
 15. Seitz, H.K. et al. (1996) Alcohol dehydrogenase in the human colon and 
rectum. Digestion, 57, 105–108.
 16. van den Brandt, P.A. et al. (1990) A large-scale prospective cohort study 
on diet and cancer in The Netherlands. J. Clin. Epidemiol., 43, 285–295.
 17. Bongaerts, B.W. et al. (2008) Alcohol consumption, type of alcoholic bev-
erage and risk of colorectal cancer at specific subsites. Int. J. Cancer, 
123, 2411–2417.
 18. Bongaerts, B.W. et  al. (2011) Alcohol consumption, alcohol dehydro-
genase 1C (ADH1C) genotype, and risk of colorectal cancer in the 
Netherlands Cohort Study on diet and cancer. Alcohol, 45, 217–225.
 19. Gezondheidsraad (2015) Richtlijnen goede voeding 2015. Den Haag: 
Gezondheidsraad: publicatienr. 2015/24. https://www.gezond-
heidsraad.nl/sites/default/files/201524_richtlijnen_goede_voed-
ing_2015.pdf (18 December 2017, date last accessed).
 20. Prentice, R.L. (1986) A case-cohort design for epidemiologic cohort 
studies and disease prevention trials. Biometrika, 73, 1–11.
 21. Casparie, M. et al. (2007) Pathology databanking and biobanking in The 
Netherlands, a central role for PALGA, the nationwide histopathology 
and cytopathology data network and archive. Cell. Oncol., 29, 19–24.
 22. Van den Brandt, P.A. et al. (1990) Development of a record linkage proto-
col for use in the Dutch Cancer Registry for Epidemiological Research. 
Int. J. Epidemiol., 19, 553–558.
 23. Goldbohm, R.A. et al. (1994) Estimation of the coverage of Dutch munic-
ipalities by cancer registries and PALGA based on hospital discharge 
data. Tijdschr Soc Gezondheidsz, 72, 80–4.
 24. van Breda, S.G. et al. (2007) Toenails: an easily accessible and long-term 
stable source of DNA for genetic analyses in large-scale epidemiologi-
cal studies. Clin. Chem., 53, 1168–1170.
 25. Hogervorst, J.G. et  al. (2014) DNA from nails for genetic analyses in 
large-scale epidemiologic studies. Cancer Epidemiol. Biomarkers Prev., 
23, 2703–2712.
 26. Goldbohm, R.A. et al. (1994) Validation of a dietary questionnaire used 
in a large-scale prospective cohort study on diet and cancer. Eur. J. Clin. 
Nutr., 48, 253–265.
 27. Goldbohm, R.A. et al. (1995) Reproducibility of a food frequency ques-
tionnaire and stability of dietary habits determined from five annually 
repeated measurements. Eur. J. Clin. Nutr., 49, 420–429.
 28. de Bakker, P.I. et al. (2005) Efficiency and power in genetic association 
studies. Nat. Genet., 37, 1217–1223.
 29. Simons, C.C. et  al. (2013) Physical activity, occupational sitting time, 
and colorectal cancer risk in the Netherlands cohort study. Am. 
J. Epidemiol., 177, 514–530.
 30. Benjamini, Y. et al. (1995) Controlling the false discovery rate: a practi-
cal and powerful approach to multiple testing. J. R. Stat. Soc. B Stat. 
Methodol., 57, 289–300.
 31. Benjamini, Y. et al. (2001) Controlling the false discovery rate in behav-
ior genetics research. Behav. Brain Res., 125, 279–284.
 32. Smith, N.L. et al. (2007) Association of genetic variations with nonfatal 
venous thrombosis in postmenopausal women. JAMA, 297, 489–498.
 33. Cao, Y. et al. (2015) Light to moderate intake of alcohol, drinking pat-
terns, and risk of cancer: results from two prospective US cohort stud-
ies. BMJ, 351, h4238.
 34. Oneta, C.M. et al. (1998) First pass metabolism of ethanol is strikingly 
influenced by the speed of gastric emptying. Gut, 43, 612–619.
 35. Erol, A. et al. (2015) Sex and gender-related differences in alcohol use 
and its consequences: contemporary knowledge and future research 
considerations. Drug Alcohol Depend., 156, 1–13.
 36. Lin, J.H. et al. (2013) Association between sex hormones and colorectal can-
cer risk in men and women. Clin. Gastroenterol. Hepatol., 11, 419–424.e1.
 37. Roshan, M.H. et al. (2016) The role of testosterone in colorectal carci-
noma: pathomechanisms and open questions. EPMA J., 7, 22.
 38. Klatsky, A.L. et al. (2014) Moderate alcohol intake and cancer: the role of 
underreporting. Cancer Causes Control, 25, 693–699.
 39. Liang, P.S. et  al. (2009) Cigarette smoking and colorectal cancer inci-
dence and mortality: systematic review and meta-analysis. Int. 
J. Cancer, 124, 2406–2415.
 40. Simonds, N.I. et al. (2016) Review of the gene-environment interaction 
literature in cancer: what do we know? Genet. Epidemiol., 40, 356–365.
 41. GTEx Portal. https://gtexportal.org/home/eqtls/bySnp?snpId=rs414754
2&tissueName=All (18 December 2017, date last accessed).
 42. Zhang, H. et  al. (2014) Identification of methylation quantitative 
trait loci (mQTLs) influencing promoter DNA methylation of alcohol 
dependence risk genes. Hum. Genet., 133, 1093–1104.
 43. Hawkins, N. et  al. (2002) CpG island methylation in sporadic colo-
rectal cancers and its relationship to microsatellite instability. 
Gastroenterology, 122, 1376–1387.
 44. Weisenberger, D.J. et al. (2006) CpG island methylator phenotype under-
lies sporadic microsatellite instability and is tightly associated with 
BRAF mutation in colorectal cancer. Nat. Genet., 38, 787–793.
 45. Curtin, K. et al. (2007) Genetic polymorphisms in one-carbon metabo-








aastricht user on 13 January 2021
388 | Carcinogenesis, 2018, Vol. 39, No. 3
colon cancer and the modifying effects of diet. Carcinogenesis, 28, 
1672–1679.
 46. Varela-Rey, M. et  al. (2013) Alcohol, DNA methylation, and cancer. 
Alcohol Res., 35, 25–35.
 47. Razzak, A.A. et al. (2011) Alcohol intake and colorectal cancer risk by 
molecularly defined subtypes in a prospective study of older women. 
Cancer Prev. Res. (Phila)., 4, 2035–2043.
 48. Schernhammer, E.S. et al. (2011) B vitamins, methionine and alcohol 
intake and risk of colon cancer in relation to BRAF mutation and CpG 
island methylator phenotype (CIMP). PLoS One, 6, e21102.
 49. Slattery, M.L. et al. (2007) Diet and lifestyle factor associations with CpG 
island methylator phenotype and BRAF mutations in colon cancer. Int. 
J. Cancer, 120, 656–663.
 50. Osier, M.V. et al. (2002) A proline-threonine substitution in codon 351 of ADH1C 
is common in Native Americans. Alcohol. Clin. Exp. Res., 26, 1759–1763.
 51. Bosron, W.F. et al. (1986) Genetic polymorphism of human liver alco-
hol and aldehyde dehydrogenases, and their relationship to alcohol 
metabolism and alcoholism. Hepatology, 6, 502–510.
 52. Höög, J.O. et al. (1986) The gamma 1 and gamma 2 subunits of human 
liver alcohol dehydrogenase. cDNA structures, two amino acid replace-
ments, and compatibility with changes in the enzymatic properties. 
Eur. J. Biochem., 159, 215–218.
 53. Xue, Y. et  al. (2012) ADH1C Ile350Val polymorphism and cancer risk: 
evidence from 35 case-control studies. PLoS One, 7, e37227.
 54. Giovannucci, E. et  al. (2003) Methylenetetrahydrofolate reductase, 
alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer 
Epidemiol. Biomarkers Prev., 12, 970–979.
 55. Homann, N. et  al. (2009) Alcohol and colorectal cancer: the role of 









aastricht user on 13 January 2021
